Joseph Catanzaro

Stock Analyst at Mizuho

(2.19)
# 2,892
Out of 5,043 analysts
101
Total ratings
38.1%
Success rate
-0.75%
Average return

Stocks Rated by Joseph Catanzaro

Nurix Therapeutics
Oct 21, 2025
Initiates: Outperform
Price Target: $24
Current: $11.09
Upside: +116.41%
Revolution Medicines
Oct 21, 2025
Initiates: Outperform
Price Target: $90
Current: $54.48
Upside: +65.20%
Celldex Therapeutics
Oct 21, 2025
Initiates: Outperform
Price Target: $48
Current: $26.72
Upside: +79.64%
Apogee Therapeutics
Oct 21, 2025
Initiates: Outperform
Price Target: $105
Current: $53.32
Upside: +96.92%
Kymera Therapeutics
Oct 21, 2025
Initiates: Outperform
Price Target: $81
Current: $58.56
Upside: +38.32%
ImmunityBio
May 20, 2025
Upgrades: Overweight
Price Target: $4.25$5
Current: $2.47
Upside: +102.43%
CytomX Therapeutics
May 15, 2025
Maintains: Overweight
Price Target: $2.5$5
Current: $3.26
Upside: +53.37%
Iovance Biotherapeutics
Feb 28, 2025
Maintains: Neutral
Price Target: $7.5$6
Current: $2.25
Upside: +166.67%
Schrödinger
Feb 27, 2025
Maintains: Overweight
Price Target: $50$45
Current: $22.52
Upside: +99.82%
Merus
Feb 13, 2025
Initiates: Overweight
Price Target: $84
Current: $94.88
Upside: -11.47%
Maintains: Overweight
Price Target: $105$110
Current: $120.94
Upside: -9.05%
Maintains: Overweight
Price Target: $37$38
Current: $38.72
Upside: -1.86%
Maintains: Overweight
Price Target: $40$15
Current: $15.04
Upside: -0.27%
Maintains: Neutral
Price Target: $52$53
Current: $66.15
Upside: -19.88%
Maintains: Overweight
Price Target: $7$10
Current: $2.23
Upside: +348.43%
Maintains: Overweight
Price Target: $10$19
Current: $1.46
Upside: +1,201.37%
Initiates: Overweight
Price Target: $19
Current: $10.18
Upside: +86.64%
Maintains: Overweight
Price Target: $12$15
Current: $3.93
Upside: +281.68%
Maintains: Overweight
Price Target: $36
Current: $31.97
Upside: +12.61%
Maintains: Overweight
Price Target: $40
Current: $7.49
Upside: +434.05%
Maintains: Overweight
Price Target: $15
Current: $11.49
Upside: +30.55%
Initiates: Overweight
Price Target: $4.5
Current: $1.26
Upside: +257.14%
Maintains: Overweight
Price Target: $26$30
Current: $2.07
Upside: +1,349.28%
Initiates: Overweight
Price Target: $20
Current: $1.46
Upside: +1,269.86%
Maintains: Overweight
Price Target: $15$10
Current: $4.22
Upside: +136.97%
Initiates: Overweight
Price Target: $18
Current: $7.50
Upside: +140.16%
Maintains: Overweight
Price Target: $30$25
Current: $1.96
Upside: +1,175.51%
Downgrades: Neutral
Price Target: $15$1.75
Current: $5.76
Upside: -69.62%
Maintains: Overweight
Price Target: $18$20
Current: $20.96
Upside: -4.58%
Downgrades: Neutral
Price Target: $25$1.5
Current: $1.70
Upside: -11.76%
Maintains: Overweight
Price Target: $240$200
Current: $10.56
Upside: +1,793.94%
Initiates: Overweight
Price Target: $35
Current: $8.23
Upside: +325.27%
Initiates: Overweight
Price Target: $60
Current: $1.03
Upside: +5,725.24%
Maintains: Overweight
Price Target: $28$18
Current: $2.59
Upside: +594.98%